- Companies
- DNA X
DNA X Valuation Multiples
DNA X is valued at $6M as of September 2026. In the last fiscal year, DNA X EBITDA was ($2M).
DNA X Overview
About DNA X
DNA X Inc operates a digital asset management platform.
Founded
1999
HQ
Employees
160
Website
Financials (Last FY)
EV
$7M
Valuation Multiples
Start free trialDNA X Financials
DNA X reported last fiscal year revenue of - and negative EBITDA of ($2M).
In the same fiscal year, DNA X generated - in gross profit, ($2M) in EBITDA losses, and had net loss of ($21M).
DNA X P&L
In the most recent fiscal year, DNA X reported revenue of - and EBITDA of ($2M).
DNA X is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
DNA X Stock Performance
DNA X has current market cap of $6M, and enterprise value of $7M.
Market Cap Evolution
DNA X's stock price is $3.91.
DNA X share price increased by 7.0% in the last 30 days.
DNA X has an EPS (earnings per share) of $-13.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $6M | 0.0% | 7.0% | - | - | $-13.88 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDNA X Valuation Multiples
DNA X trades at (3.4x) EV/EBITDA.
DNA X Financial Valuation Multiples
As of September 29, 2026, DNA X has market cap of $6M and EV of $7M.
DNA X has a P/E ratio of (0.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DNA X Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


DNA X Margins & Growth Rates
DNA X Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
DNA X Operational KPIs
DNA X's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
DNA X Competitors
DNA X competitors include Avenir Telecom, artec technologies, Hammer Technology Hldgs, Pentanet, Astro Corp, Adeunis RF, Maxcom, Strategic Management, Optronics Technologies and Boxlight.
Most DNA X public comparables operate across Computer Hardware, Telecom Service Providers, Networking Hardware and DeepTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $12M | ($5M) | - | - | - | - | |||
| $4M | $668K | 1.6x | 1.4x | 8.7x | 8.5x | |||
| - | ($4M) | - | - | (1.6x) | - | |||
| $16M | $494K | 0.6x | 0.6x | 18.2x | - | |||
| $3M | ($925K) | 4.7x | - | (13.1x) | - | |||
| $5M | ($2M) | 1.1x | - | (2.5x) | - | |||
| $27M | $285K | 0.2x | - | 22.0x | - | |||
| - | - | - | - | - | - | |||
This data is available for Pro users. Sign up to see all DNA X competitors and their valuation data. Start Free Trial | ||||||||
DNA X VC Funding History
Before going public, DNA X raised $35M in total equity funding, across 2 rounds.
DNA X Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DNA X
| When was DNA X founded? | DNA X was founded in 1999. |
| Where is DNA X headquartered? | DNA X is headquartered in United States. |
| How many employees does DNA X have? | As of today, DNA X has over 160 employees. |
| Is DNA X publicly listed? | Yes, DNA X is a public company listed on Nasdaq. |
| What is the stock symbol of DNA X? | DNA X trades under SONM ticker. |
| When did DNA X go public? | DNA X went public in 2019. |
| Who are competitors of DNA X? | DNA X main competitors include Avenir Telecom, artec technologies, Hammer Technology Hldgs, Pentanet, Astro Corp, Adeunis RF, Maxcom, Strategic Management, Optronics Technologies, Boxlight. |
| What is the current market cap of DNA X? | DNA X's current market cap is $6M. |
| Is DNA X profitable? | No, DNA X is not profitable. |
| What is the current net income of DNA X? | DNA X's last 12 months net income is ($21M). |
| How many companies DNA X has acquired to date? | DNA X hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies DNA X has invested to date? | DNA X hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to DNA X
Lists including DNA X
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




